Longenesis

Riga, Latvia Founded: 2017 • Age: 9 yrs
Digital platform for healthcare research and patient engagement

About Longenesis

Longenesis is a company based in Riga (Latvia) founded in 2017 by Sergey Jakimov, Emil Syundyukov, and Garri Zmudze. Longenesis has raised $1.19 million across 2 funding rounds from investors including EIT Health, Rustam Gilfanov and Ilya Suharenko. The company has 16 employees. Longenesis offers products and services including Engage and Curator. Longenesis operates in a competitive market with competitors including Zimmer Biomet, CipherHealth, ConnectiveRx, ixLayer and Hyro, among others.

  • Headquarter Riga, Latvia
  • Employees 16
  • Founders Sergey Jakimov, Emil Syundyukov, Garri Zmudze
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website longenesis.com
  • Social LinkedIn X Facebook
  • Legal Name Longenesis
Key Metrics
  • Annual Revenue
    $781.22 K (USD)
    66
    as on Dec 31, 2022
  • Net Profit
    $54.32 K (USD)
    -44
    as on Dec 31, 2022
  • Total Equity Funding
    $1.19M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.19M (USD), Seed

    Jun 2021

  • Investors
    EIT Health

    & 2 more

  • Employee Count
    16

Products & Services of Longenesis

Longenesis offers a comprehensive portfolio of products and services, including Engage and Curator.

Engage
Patient Engagement Platform

Platform for improving patient journeys and adherence in healthcare research.

Curator
Data Curation Tool

Tool for safe metadata exposure and collaborative research data management.

Funding Insights of Longenesis

Longenesis has successfully raised a total of $1.19M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.19 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.19M
  • Total Rounds 2
  • Last Round Seed — $1.19M
  • Investors Count 3

All 2 funding rounds of Longenesis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2021$1.19MSeed–Rustam Gilfanov
Jun 2020–Grant––
Valuation history

3 investors in total: 1 institutional and 2 angel.

Investors in Longenesis

Longenesis has secured backing from 3 investors, including angel and venture fund investors. Prominent investors backing the company include EIT Health, Rustam Gilfanov and Ilya Suharenko.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Healthcare startups are accelerated and incubated through specialized programs.
2015eithealth.euMunich, Germany

Rustam Gilfanov

-
–unknown_3486fe95336248aea-

Ilya Suharenko

-
–unknown_0eb93d6229ce47809-
Premium access

Investor details for Longenesis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Longenesis

16 people are tracked at Longenesis (5 in leadership, 4 in board & advisors, 7 in team); the tracked headcount is 16.

NameRoleGroup
Sergey Jakimov
Co-FounderLeadership
Emil Syundyukov
Co-Founder & CEOLeadership
Garri Zmudze
Co-FounderLeadership
Agnese Veckalne
COOLeadership
Arnolds Bogdanovs
Head Of TechnologyLeadership
Daniels Pavļuts
AdvisorBoard & advisors
Leesa Soulodre
AdvisorBoard & advisors
Sergejs Jakimovs
Board MemberBoard & advisors
Alex Zhavoronkov
AdvisorBoard & advisors
Lonija Kazlauska
Legal CounselTeam
Renda Forstmane
Frontend DeveloperTeam
Juris Ruseckis
DevOps EngineerTeam
Zaiga Kluine
Quality Assurance EngineerTeam
Martins Mednis
DeveloperTeam
Lucy Ojomoko
Blockchain AI Program ManagerTeam
Ieva Danovska
Product ManagerTeam
Premium access

Complete people profiles for Longenesis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Longenesis

3 dated milestones of Longenesis across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Longenesis is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Seed, of $1.2M.

Competitors of Longenesis

Longenesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zimmer Biomet, CipherHealth, ConnectiveRx, ixLayer and Hyro, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
zimmerbiomet.com1927Warsaw, United States$1.73M18,000
Medical devices for multiple health purposes are manufactured.
cipherhealth.com2009New York, United States$37.58M–
SaaS based tools for patient engagement
connectiverx.com2008Hanover, United States$300M684
Provider of patient engagement and prior authorization solutions
ixlayer.com2017San Francisco, United States$75M–
Provider of cloud-based solution for precision and population health testing
hyro.ai2014New York, United States$114.6M–
An AI-based conversational platform is provided for healthcare task automation.
patientpoint.com1987Cincinnati, United States$140M382
Patient engagement solutions for healthcare providers at point of care
enverahealth.com2015Richmond, United States$25.39M118
Digital patient engagement platforms are provided for healthcare providers.
getwellnetwork.com1999Bethesda, United States$19M268
Interactive software is developed for patient engagement in hospital care.
upfronthealthcare.com2015Chicago, United States$95.54M45
Provider of data analytics platform to help clinics schedule and allocate resources
causaly.com2017London, United Kingdom$90.72M62
AI-based data-mining tools for scientific evidence discovery are provided.
Premium access

Detailed competitors of Longenesis

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Longenesis

Premium access

Complete news archive for Longenesis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Longenesis

10 companies that operate in the same segment as Longenesis (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 713.57 M––
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M233
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M––
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 508.73 M––
App-based health insurance is offered to individuals and businesses.
2016Paris, FranceUSD 863.12 M––
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M–
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M––
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Longenesis

Longenesis was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Longenesis is headquartered in Riga, Latvia.

Emil Syundyukov is the current CEO of Longenesis. They have also founded this company.

Longenesis is a funded company, having raised a total of $1.19M across 2 funding rounds to date.

Longenesis has 16 employees.

Annual revenue of Longenesis is $781.22K as on Dec 31, 2022.

Digital platform for healthcare research and patient engagement. The company offers digital tools for patient cohort discovery, patient engagement and consent management for life science companies and healthcare institutions.

Longenesis's top competitors include Hyro, CipherHealth and ixLayer.

Longenesis offers Engage and Curator.

Longenesis has 3 investors. Key investors include EIT Health, Rustam Gilfanov, and Ilya Suharenko.

Longenesis operates through Longenesis.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available